The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-Morpholino-2-((2-(pyrrolidin-1-yl)quinolin-8-yl)oxy)ethan-1-one ID: ALA4745312
PubChem CID: 162648533
Max Phase: Preclinical
Molecular Formula: C19H23N3O3
Molecular Weight: 341.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(COc1cccc2ccc(N3CCCC3)nc12)N1CCOCC1
Standard InChI: InChI=1S/C19H23N3O3/c23-18(22-10-12-24-13-11-22)14-25-16-5-3-4-15-6-7-17(20-19(15)16)21-8-1-2-9-21/h3-7H,1-2,8-14H2
Standard InChI Key: SYFSZAQMHXUNGM-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
23.6559 -1.6839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6547 -2.5034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3628 -2.9124 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3610 -1.2750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0696 -1.6803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0703 -2.4993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7789 -2.9064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4871 -2.4955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4824 -1.6734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7733 -1.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9471 -2.9087 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2008 -2.5758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6535 -3.1826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0616 -3.8907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8610 -3.7213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7806 -3.7235 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.4891 -4.1307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1960 -3.7206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9045 -4.1277 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1943 -2.9034 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.9039 -4.9498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6084 -5.3569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3177 -4.9503 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.3179 -4.1322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6089 -3.7206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 11 1 0
2 11 1 0
7 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
19 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 341.41Molecular Weight (Monoisotopic): 341.1739AlogP: 2.07#Rotatable Bonds: 4Polar Surface Area: 54.90Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.01CX LogP: 1.98CX LogD: 1.98Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.85Np Likeness Score: -1.94
References 1. Wang M,Zhang G,Zhao J,Cheng N,Wang Y,Fu Y,Zheng Y,Wang J,Zhu M,Cen S,He J,Wang Y. (2021) Synthesis and antiviral activity of a series of novel quinoline derivatives as anti-RSV or anti-IAV agents., 214 [PMID:33571829 ] [10.1016/j.ejmech.2021.113208 ]